New Key Statistics Module, Z-Score and F-Score
NAS:AERI Key Ratios
| Market Cap $ M | 753.62 |
| Enterprise Value $ M | 918.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 3.36 |
| Price/Free Cash Flow | 331.52 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 213.00 |
| EPS (TTM) $ | -0.77 |
| Beneish M-Score | -2.28 |
| 10-y EBITDA Growth Rate % | 11.90 |
| 5-y EBITDA Growth Rate % | 37.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -39.51 |
| EV-to-EBITDA | -298.68 |
| PEG | -- |
| Shares Outstanding M | 49.42 |
| Net Margin (%) | -17.09 |
| Operating Margin % | -12.49 |
| Pre-tax Margin (%) | -16.47 |
| Quick Ratio | 1.92 |
| Current Ratio | 2.27 |
| ROA % (ttm) | -9.42 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -24.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.68 |
AERI Number of Guru Trades
AERI Volume of Guru Trades
Gurus Latest Trades with NAS:AERI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AERI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aerie Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AERI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers